User profiles for Tony M. Korman
Tony KormanMonash Infectious Diseases, Monash Health, Monash University Verified email at monash.edu Cited by 9443 |
SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia
…, RJ Pierce, JG Armstrong, TM Korman… - Clinical infectious …, 2008 - academic.oup.com
Background . Existing severity assessment tools, such as the pneumonia severity index (PSI)
and CURB-65 (tool based on confusion, urea level, respiratory rate, blood pressure, and …
and CURB-65 (tool based on confusion, urea level, respiratory rate, blood pressure, and …
Treatment Outcomes for Serious Infections Caused by Methicillin-Resistant Staphylococcus aureus with Reduced Vancomycin Susceptibility
…, PB Ward, PGP Charles, TM Korman… - Clinical Infectious …, 2004 - academic.oup.com
Although infections caused by methicillin-resistant Staphylococcus aureus with reduced
vancomycin susceptibility (SA-RVS) have been reported from a number of countries, including …
vancomycin susceptibility (SA-RVS) have been reported from a number of countries, including …
Isolation and rapid sharing of the 2019 novel coronavirus (SARS‐CoV‐2) from the first patient diagnosed with COVID‐19 in Australia
Objectives To describe the first isolation and sequencing of SARS ‐CoV‐2 in Australia and
rapid sharing of the isolate. Setting SARS ‐CoV‐2 was isolated from a 58‐year‐old man from …
rapid sharing of the isolate. Setting SARS ‐CoV‐2 was isolated from a 58‐year‐old man from …
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
…, JO Robinson, TM Korman… - Journal of Infectious …, 2011 - academic.oup.com
(See the editorial commentary by Holland and Fowler Jr, on pages 329–31 .) Background.
There are concerns about reduced efficacy of vancomycin in patients with Staphylococcus …
There are concerns about reduced efficacy of vancomycin in patients with Staphylococcus …
The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy
…, R Stirling, AA Wright, TM Korman… - Clinical Infectious …, 2008 - academic.oup.com
Background . Available data on the etiology of community-acquired pneumonia (CAP) in
Australia are very limited. Local treatment guidelines promote the use of combination therapy …
Australia are very limited. Local treatment guidelines promote the use of combination therapy …
Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis
Staphylococcus epidermidis is a conspicuous member of the human microbiome, widely
present on healthy skin. Here we show that S. epidermidis has also evolved to become a …
present on healthy skin. Here we show that S. epidermidis has also evolved to become a …
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia
…, WJ Munckhof, JO Robinson, TM Korman… - Antimicrobial agents …, 2013 - Am Soc Microbiol
A ratio of the vancomycin area under the concentration-time curve to the MIC (AUC/MIC) of
≥400 has been associated with clinical success when treating Staphylococcus aureus …
≥400 has been associated with clinical success when treating Staphylococcus aureus …
[HTML][HTML] Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality
Introduction To estimate the incidence of intensive care unit (ICU)-acquired bloodstream
infection (BSI) and its independent effect on hospital mortality. Methods We retrospectively …
infection (BSI) and its independent effect on hospital mortality. Methods We retrospectively …
Increasing tolerance of hospital Enterococcus faecium to handwash alcohols
…, EA Grabsch, D Kotsanas, TM Korman… - Science translational …, 2018 - science.org
Alcohol-based disinfectants and particularly hand rubs are a key way to control hospital
infections worldwide. Such disinfectants restrict transmission of pathogens, such as multidrug-…
infections worldwide. Such disinfectants restrict transmission of pathogens, such as multidrug-…
Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death
Background. Longer-term morbidity and outcomes of Cryptococcus gattii infection are not
described. We analyzed clinical, microbiological, and outcome data in Australian patients …
described. We analyzed clinical, microbiological, and outcome data in Australian patients …